{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:31:56Z","timestamp":1775597516959,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00415-024-12596-7","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T14:29:43Z","timestamp":1721917783000},"page":"7046-7053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms"],"prefix":"10.1007","volume":"271","author":[{"given":"Hiroshi","family":"Mitoma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-4380","authenticated-orcid":false,"given":"Mario","family":"Manto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"12596_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-444-51892-7.00011-5","volume":"103","author":"M Hadjivassiliou","year":"2012","unstructured":"Hadjivassiliou M (2012) Immune-mediated acquired ataxias. Handb Clin Neurol 103:189\u2013199","journal-title":"Handb Clin Neurol"},{"key":"12596_CR2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"Mitoma H, Adhikari K, Aeschlimann D et al (2016) Consensus Paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum 15:2313\u20132332","journal-title":"Cerebellum"},{"key":"12596_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","volume":"17","author":"H Mitoma","year":"2019","unstructured":"Mitoma H, Manto M, Hampe CS (2019) Immune-mediated cerebellar ataxias: Practical guidelines and therapeutic challenges. Curr Neuropharmacol 17:33\u201358","journal-title":"Curr Neuropharmacol"},{"key":"12596_CR4","doi-asserted-by":"crossref","unstructured":"Hadjivassiliou M, Mitoma H, Manto M (2019) Autoimmune ataxia. In; Mitoma H, Manto M (eds). Neuroimmune diseases; From cells to the living brain. Springer Nature, Switzerland AG, pp 599\u2013620","DOI":"10.1007\/978-3-030-19515-1_19"},{"key":"12596_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14802\/jmd.20040","volume":"14","author":"H Mitoma","year":"2021","unstructured":"Mitoma H, Manto M, Hadjivassiliou M (2021) Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J Mov Disord 14:10\u201328","journal-title":"J Mov Disord"},{"key":"12596_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s12311-023-01550-4","volume":"23","author":"M Manto","year":"2024","unstructured":"Manto M, Hadjivassiliou M, Baizabal-Carvallo JF et al (2024) Consensus paper: latent autoimmune cerebellar ataxia (LACA). Cerebellum 23:838\u2013855","journal-title":"Cerebellum"},{"key":"12596_CR7","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(98)05342-2","volume":"352","author":"M Hadjivassiliou","year":"1998","unstructured":"Hadjivassiliou M, Gr\u00fcnewald RA, Chattopadhyay AK et al (1998) Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet 352:1582\u20131585","journal-title":"Lancet"},{"key":"12596_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"J Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B et al (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Study of 14 patients. Arch Neurol 58:225\u2013230","journal-title":"Arch Neurol"},{"key":"12596_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ana.410140603","volume":"14","author":"JE Greenlee","year":"1983","unstructured":"Greenlee JE, Brashear HR (1983) Antibodies to cerebellar degeneration and ovarian carcinoma. Ann Neurol 14:609\u2013613","journal-title":"Ann Neurol"},{"key":"12596_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/ene.12368","volume":"21","author":"F Ducray","year":"2014","unstructured":"Ducray F, Demarquay G, Graus F et al (2014) Seronegative paraneoplastic cerebellar degeneration: The PNS Euronetwork experience. Eur J Neurol 21:731\u2013735","journal-title":"Eur J Neurol"},{"issue":"10","key":"12596_CR11","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1212\/01.WNL.0000069606.82919.04","volume":"60","author":"M Abele","year":"2003","unstructured":"Abele M, Sch\u00f6ls L, Schwartz S, Klockgether T (2003) Prevalence of antigliadin antibodies in ataxia patients. Neurology 60(10):1674\u20131675","journal-title":"Neurology"},{"issue":"3","key":"12596_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009698","volume":"5","author":"S Boscolo","year":"2010","unstructured":"Boscolo S, Lorenzon A, Sblattero D et al (2010) Anti transglutaminase antibodies cause ataxia in mice. PLoS ONE 5(3):e9698","journal-title":"PLoS ONE"},{"issue":"3","key":"12596_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ana.21450","volume":"64","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Aeschlimann P, Strigun A et al (2008) Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 64(3):332\u2013343","journal-title":"Ann Neurol"},{"issue":"2","key":"12596_CR14","first-page":"149","volume":"68","author":"L Lutteri","year":"2010","unstructured":"Lutteri L, Sagot C, Chapelle JP (2010) Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays. Ann Biol Clin (Paris) 68(2):149\u2013156","journal-title":"Ann Biol Clin (Paris)"},{"key":"12596_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/978-3-031-15070-8_87","volume-title":"Essentials of cerebellum and cerebellar disorders","author":"M Hadjivassiliou","year":"2023","unstructured":"Hadjivassiliou M, Mitoma H (2023) Immune-mediated cerebellar ataxias. In: Gruol DL, Koibuchi N, Manto M, Molinari M, Schmahmann JD, Shen Y (eds) Essentials of cerebellum and cerebellar disorders, 2nd edn. Springer, Switzerland, pp 575\u2013581","edition":"2"},{"key":"12596_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 8:e1014","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"12596_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509\u2013517","journal-title":"J Neurol"},{"key":"12596_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinex-Hernandez E, Dalmau J (2011) Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77:179\u2013189","journal-title":"Neurology"},{"key":"12596_CR19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F (2017) Autoantibodies to synaptic receptors and neuronal cell surface protein in autoimmune diseases of the central nervous system. Physiol Rev 97:839\u2013887","journal-title":"Physiol Rev"},{"key":"12596_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA et al (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81:298\u2013309","journal-title":"Ann Neurol"},{"key":"12596_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","volume":"32","author":"A Kunchok","year":"2019","unstructured":"Kunchok A, Zekeridou A, McKeon A (2019) Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 32:452\u2013458","journal-title":"Curr Opin Neurol"},{"key":"12596_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/mds.22129","volume":"23","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Boscolo S, Tongiorgi E et al (2008) Cerebellar ataxia as a possible organ specific autoimmune disease. Mov Disord 23:1270\u20131277","journal-title":"Mov Disord"},{"key":"12596_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J et al (2020) Diagnostic criteria for primary autoimmune cerebellar ataxia (PACA)-Guidelines from an International Task Force on Immune Mediated Cerebellar Ataxia. Cerebellum 19:605\u2013610","journal-title":"Cerebellum"},{"issue":"4","key":"12596_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ene.15648","volume":"30","author":"A Schwarzwald","year":"2023","unstructured":"Schwarzwald A, Salmen A, Le\u00f3n Betancourt AX et al (2023) Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature. Eur J Neurol 30(4):1135\u20131147","journal-title":"Eur J Neurol"},{"key":"12596_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/jnnp-2016-314863","volume":"88","author":"M Hadjivassiliou","year":"2017","unstructured":"Hadjivassiliou M, Martindale J, Shanmugarajah P et al (2017) Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J Neurol Neurosurg Psychiatry 88:301\u2013309","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12596_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/0028-3886.115056","volume":"61","author":"WJ Guan","year":"2013","unstructured":"Guan WJ, Liu XJ, Tang BS et al (2013) Gluten ataxia of sporadic and hereditary cerebellar ataxia in patients from mainland China. Neurol India 61:226\u2013230","journal-title":"Neurol India"},{"key":"12596_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2337\/diab.42.2.359","volume":"42","author":"T Tuomi","year":"1993","unstructured":"Tuomi T, Groop LC, Zimmet PZ et al (1993) Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359\u2013362","journal-title":"Diabetes"},{"key":"12596_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1464-5491.1994.tb00275.x","volume":"118","author":"PZ Zimmet","year":"1994","unstructured":"Zimmet PZ, Tuomi T, Mackay IR et al (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 118:299\u2013303","journal-title":"Diabet Med"},{"key":"12596_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/dmrr.2779","volume":"32","author":"G Huang","year":"2016","unstructured":"Huang G, Yin M, Xiang Y et al (2016) Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up. Diabetes Metab Res Rev 32:615\u2013622","journal-title":"Diabetes Metab Res Rev"},{"key":"12596_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12311-019-01091-9","volume":"19","author":"H Mitoma","year":"2019","unstructured":"Mitoma H, Buffo A, Gelfo F et al (2019) Consensus paper. Cerebellar reserve: from cerebellar physiology to cerebellar disorders. Cerebellum 19:131\u2013153","journal-title":"Cerebellum"},{"key":"12596_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12311-018-0925-6","volume":"17","author":"H Mitoma","year":"2018","unstructured":"Mitoma H, Manto M, Hampe CS (2018) Time is cerebellum. Cerebellum 17:387\u2013391","journal-title":"Cerebellum"},{"key":"12596_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108629","volume":"194","author":"M Yamasaki","year":"2021","unstructured":"Yamasaki M, Aiba A, Kano M et al (2021) mGluR1 signaling in cerebellar Purkinje cells: Subcellular organization and involvement in cerebellar function and disease. Neuropharmacology 194:108629","journal-title":"Neuropharmacology"},{"key":"12596_CR33","doi-asserted-by":"publisher","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M, Pedrol MP, Maudes E et al (2020) Clinical features prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology 95:e3012\u2013e3025","journal-title":"Neurology"},{"key":"12596_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87:521\u2013528","journal-title":"Neurology"},{"key":"12596_CR35","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","volume":"91","author":"S Mu\u00f1iz-Castrillo","year":"2020","unstructured":"Mu\u00f1iz-Castrillo S, Joubert B, Elsensohn M-H et al (2020) Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features. J Neurol Neurosurg Psychiatry 91:1076\u20131084","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12596_CR36","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000371","volume":"4","author":"B Joubert","year":"2017","unstructured":"Joubert B, Gobert F, Thomas L et al (2017) Autoimmune episodic ataxia with anti-CASPR2 antibody-associated encephalitis. Neurol Neuroimmunol Neuroinflamm 4:e371","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12596_CR37","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L et al (2014) DPPX potassium channel antibody; frequency, clinical accompaniments and outcomes in 20 patients. Neurology 83:1797\u20131803","journal-title":"Neurology"},{"key":"12596_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/brainsci12091165","volume":"12","author":"M Hadjivassiliou","year":"2022","unstructured":"Hadjivassiliou M, Manto M, Mitoma H (2022) Rare etiologies in immune-mediated cerebellar ataxias: diagnostic challenges. Brain Sci 12:1165","journal-title":"Brain Sci"},{"key":"12596_CR39","first-page":"508","volume":"8","author":"S Walloe","year":"2014","unstructured":"Walloe S, Pakkenberg B, Fabriciusm K (2014) Stereological estimation of total cell numbers in the human cerebral and cerebellar cortex. Front Hum Neurosci 8:508","journal-title":"Front Hum Neurosci"},{"key":"12596_CR40","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","volume":"64","author":"M Koga","year":"2005","unstructured":"Koga M, Gilbert M, Li J et al (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605\u20131611","journal-title":"Neurology"},{"key":"12596_CR41","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1167\/iovs.08-3333","volume":"50","author":"JX Liu","year":"2009","unstructured":"Liu JX, Willison HJ, Pedrosa-Domell\u00f6f F (2009) Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 50:3226\u20133232","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12596_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/630602","volume":"2013","author":"MP Zaborowski","year":"2013","unstructured":"Zaborowski MP, Michalak S (2013) Cell-mediated immune response in paraneoplastic neurological syndromes. Clin Dev Immunol 2013:630602","journal-title":"Clin Dev Immunol"},{"key":"12596_CR43","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.410270515","volume":"27","author":"J Dalmau","year":"1990","unstructured":"Dalmau J, Furneaux HM, Gralla RJ et al (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer\u2013a quantitative western blot analysis. Ann Neurol 27:544\u2013552","journal-title":"Ann Neurol"},{"key":"12596_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","volume":"85","author":"P Gozzard","year":"2015","unstructured":"Gozzard P, Woodhall M, Chapman C et al (2015) Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study. Neurology 85:235\u2013239","journal-title":"Neurology"},{"key":"12596_CR45","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai Y, Ishida M, Tanaka Y et al (2002) Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA 99:12293\u201312297","journal-title":"Proc Natl Acad Sci USA"},{"key":"12596_CR46","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350\u20131355","journal-title":"Science"},{"key":"12596_CR47","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/WCO.0000000000000503","volume":"30","author":"M Touat","year":"2017","unstructured":"Touat M, Talmasov D, Ricard D et al (2017) Neurological toxicities associated with immune-checkpoint inhibitors. Curr Opin Neurol 30:659\u2013668","journal-title":"Curr Opin Neurol"},{"key":"12596_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","volume":"16","author":"F Graus","year":"2019","unstructured":"Graus F, Dalmau J (2019) Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol 16:535\u2013548","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12596-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T04:01:57Z","timestamp":1727928117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12596-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["12596"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12596-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}